Determination of serum amantadine by liquid chromatography-tandem mass spectrometry

Clinica Chimica Acta

Volumn 359, Issue 1-2, 2005, Pages 125-131

  Arndt, Torsten ^a   Guessregen, Brunhilde ^a   Hohl, Axel ^a   Reis, Janine ^b  

^a Bioscientia Center for Human Genetics   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Adamantylamine; Amantadine; Automation; LC MS MS; Liquid chromatography tandem mass spectrometry; Serum; Therapeutic drug monitoring

Indexed keywords

ACETONITRILE; AMANTADINE; FORMIC ACID; PYRIDINIUM DERIVATIVE;

ARTICLE; BLOOD ANALYSIS; CALIBRATION; CENTRIFUGATION; DILUTION; ELECTROSPRAY MASS SPECTROMETRY; EXTRACTION; FLOW RATE; HUMAN; LIQUID CHROMATOGRAPHY; POSITIVE ION ELECTROSPRAY; PRECIPITATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; TANDEM MASS SPECTROMETRY;

AMANTADINE; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

HEPATITIS C VIRUS;

EID: 23644451328     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.03.040     Document Type: Article

References (20)

1. W.E. Bleidner, J.B. Harmon, W.E. Hewes, T.E. Lynes, and E.C. Hermann Absorption, distribution and excretion of amantadine hydrochloride J Pharmacol Exp Ther 150 1965 484 490
2. G. Stiver The treatment of influenza with antiviral drugs CMAJ 168 2003 49 56
3. A.C. Schmidt Antiviral therapy for influenza: a clinical and economic comparative review Drugs 64 2004 2031 2046
4. J.S. Goff, R.M. Reveille, and J. Johnson Treatment of chronic hepatitis C with amantadine Dig Dis Sci 45 2000 1389 1391
5. J.P. Smith, T.R. Riley 3rd, S. Bingaman, and D.T. Mauger Amantadine therapy for chronic hepatitis C: a dose escalation study Am J Gastroenterol 99 2004 1099 1104
6. P.J. Blanchet, L.V. Metman, and T.N. Chase Renaissance of amantadine in the treatment of Parkinson's disease Adv Neurol 91 2003 251 257
7. J. Romrell, H.H. Fernandez, and M.S. Okun Rational for current therapies in Parkinson's disease Expert Opin Pharmacother 4 2003 1747 1761
8. P. Brañas, R. Jordan, A. Fry-Smith, A. Burls, and C. Hyde Treatments for fatigue in multiple sclerosis: a rapid and systematic review Health Technol Assess 4 2000 1 71
9. L.B. Krupp Fatigue in multiple sclerosis: definition, pathophysiology and treatment CNS Drugs 17 2003 225 234
10. M.P. Hill, P. Ravenscroft, E. Bezard, A.R. Crossmann, J.M. Brotchie, and A. Michel Levetirazetam potentiates the antidyskinetic action of amantadine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease J Pharmacol Exp Ther 310 2004 386 394
11. T. Taiminen, and S.K. Jaaskelainen Intense and recurrent deja vu experiences related to amantadine and phenylpropanolamine in a healthy male J Clin Neurosci 8 2001 460 462
12. P. Biandrate, G. Tognoni, G. Belvedere, A. Frigerio, M. Rizzo, and P.L. Morselli A gas chromatographic method for the determination of amantadine in human plasma J Chromatogr 74 1972 31 34
13. D. Rakestraw Determination of amantadine in human plasma by capillary gas chromatography using electron-capture detection following derivatization with pentafluorobenzoyl chloride J Pharm Biomed Anal 11 1993 699 703
14. F.A.L. Van der Horst, J. Teeuwsen, J.J.M. Holthuis, and U.A.Th. Brinkman High-performance liquid chromatographic determination of amantadine in urine after micelle-mediated pre-column derivatization with 1-fluoro-2,4- dinitrobenzene J Pharm Biomed Anal 8 1990 799 804
15. F.-X. Zhou, and I.S. Krull Direct determination of adamantanamine in plasma and urine with automated solid phase derivatization J Chromatogr 619 1993 93 101
16. W. Wesemann, J.D. Schollmeyer, and G. Sturm Gaschromatographische und massenspektrometrische Untersuchungen über harnpflichtige Metabolite von Adamantanaminen Arzneim-Forsch/Drug Res 27 1977 1471 1477
17. H.J. Leis, G. Fauler, and W. Windischhofer Quantitative analysis of memantine in human plasma by gas chromatography/negative ion chemical ionization/mass spectrometry J Mass Spectrom 37 2002 477 480
18. T. Arndt, B. Guessregen, A. Hohl, and B. Heicke Total plasma homocysteine measured by liquid chromatography-tandem mass spectrometry with use of 96-well plates Clin Chem 50 2004 755 757
19. M. Schulz, and A. Schmoldt Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics Pharmazie 58 2003 447 474
20. F. Streit, M. Shipkova, V.W. Armstrong, and M. Oellerich Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid Clin Chem 50 2003 152 159